3,328
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique

ORCID Icon, ORCID Icon, , , , , , , ORCID Icon & show all
Article: 1940764 | Received 21 Dec 2020, Accepted 04 Jun 2021, Published online: 06 Jul 2021

References

  • Cori A, Ayles H, Beyers N, et al. HPTN 071 PopART Study Team. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PloS One. 2014;9:e84511.
  • Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9:e1001245.
  • World Health Organization. WHO | guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV [Internet]. Geneva, Switzerland: World Health Organization; 2012 Jul [cited 2020 Apr 27]. Available from: https://www.who.int/hiv/pub/guidance_prep/en/
  • UNAIDS. HIV prevention 2020 road map — accelerating HIV prevention to reduce new infections by 75% [Internet]. Geneva, Switzerland; 2016; p. 36. Available from: https://www.unaids.org/sites/default/files/media_asset/hiv-prevention-2020-road-map_en.pdf
  • Burns DN, Grossman C, Turpin J, et al. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies. Curr HIV/AIDS Rep. 2014 Dec 1;11:393–10.
  • Hanscom B, Janes HE, Guarino PD, et al. Preventing HIV-1 infection in women using oral pre-exposure prophylaxis: a meta-analysis of current evidence. J Acquir Immune Defic Syndr 1999. 2016 Dec 15;73:606–608.
  • Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. N Engl J Med. 2012 Aug 2;367:399–410.
  • Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012 Aug 2;367:423–434.
  • Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Lond Engl. 2013 Jun 15;381:2083–2090.
  • Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African Women. N Engl J Med. 2015 Feb 5;372:509–518.
  • Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African Women. N Engl J Med. 2012 Aug 2;367:411–422.
  • Bellan SE, Fiorella KJ, Melesse DY, et al. Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet. 2013 May 4;381:1561–1569.
  • Chemaitelly H, Awad SF, Abu-Raddad LJ. The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa. Epidemics. 2014 Mar 1;6:1–9.
  • Tabana H, Doherty T, Rubenson B, et al. ‘Testing together challenges the relationship’: consequences of HIV testing as a couple in a high HIV prevalence setting in rural South Africa. PLoS ONE [Internet]. 2013 Jun 18 [cited 2020 Apr 27];8:e66390. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688905/
  • Bunnell RE, Nassozi J, Marum E, et al. Living with discordance: knowledge, challenges, and prevention strategies of HIV-discordant couples in Uganda. AIDS Care. 2005 Nov 1;17:999–1012.
  • Ahmed N, Pike C, Bekker L-G. Scaling up pre-exposure prophylaxis in sub-Saharan Africa. Curr Opin Infect Dis. 2019 Feb;32:24–30.
  • Mugo NR, Ngure K, Kiragu M, et al. PrEP for Africa: what we have learnt and what is needed to move to program implementation. Curr Opin HIV AIDS. 2016 Jan;11:80–86.
  • Pepfar ICAP. Avaliação do piloto da implementação da PrEP na Zambézia, 2019. Zambézia Province, Mozambique; 2020. Feb; p. 10
  • IaM I. Inquérito de Indicadores de Imunização, Malária e HIV/SIDA em Moçambique (IMASIDA 2015). Maputo: INS; 2017.
  • Moon TD, Blevins M, Green AF, et al. A: improving the health and livelihoods of children, women and families in the Province of Zambezia, Republic of Mozambique [Internet]. Nashville, TN: Vanderbilt University; 2015 [cited 2020 Apr 27]. Available from: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.738.6190&rep=rep1&type=pdf
  • National Institute of Statistics (INE) (Mozambique). Mozambique population and housing census 2017 [Internet]. Mozambique: National Institute of Statistics (INE); 2017. Available from: http://www.ine.gov.mz/operacoes-estatisticas/censos/censo-2007/censo-2017/divulgacao-de-resultados-preliminares-do-iv-rgph-2017.pdf/view
  • Guest G, Bunce A, Johnson L. How many interviews are enough?: an experiment with data saturation and variability. Field Methods. 2006 Feb;18:59–82.
  • Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32:513–531.
  • Haberer JE, Bangsberg DR, Baeten JM, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS Lond Engl. 2015 Jul 17;29:1277–1285.
  • Wingood GM, Rubtsova A, DiClemente RJ, et al. A new paradigm for optimizing HIV intervention synergy the role of interdependence in integrating HIV prevention interventions. J Acquir Immune Defic Syndr 1999. 2013 Jun;63:S108–13.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
  • Zeelen J, Wijbenga H, Vintges M, et al. Beyond silence and rumor: storytelling as an educational tool to reduce the stigma around HIV/AIDS in South Africa. Health Educ. 2010 Jan 1;110:382–398.
  • Tobin PKJ, Snyman R. Once upon a time in Africa: a case study of storytelling for knowledge sharing. Aslib Proc New Inf Perspect. 2008 Mar 21;60:130–142.
  • Palacios JF, Salem B, Hodge FS, et al. Storytelling: a qualitative tool to promote health among vulnerable populations. J Transcult Nurs Off J Transcult Nurs Soc. 2015 Sep;26:346–353.
  • Jiwatram-Negrón T, El-Bassel N. Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions. AIDS Behav. 2014 Oct;18:1864–1887.
  • Fatti G, Shaikh N, Jackson D, et al. Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa. PLOS ONE. 2017 Jul 27;12:e0181691.
  • Morton JF, Celum C, Njoroge J, et al. Counseling framework for HIV-serodiscordant couples on the integrated use of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention. J Acquir Immune Defic Syndr 1999. 2017 Jan 1;74:S15–22.
  • Medley A, Baggaley R, Bachanas P, et al. Maximizing the impact of HIV prevention efforts: interventions for couples. AIDS Care. 2013;25:1569–1580.
  • Hatcher AM, Darbes L, Kwena Z, et al. Pathways for HIV prevention behaviors following a home-based couples intervention for pregnant women and male partners in Kenya. AIDS Behav. 2020 Jul 1;24:2091–2100.
  • Heffron R, Ngure K, Velloza J, et al. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness. J Int AIDS Soc. 2019;22:e25261.
  • Musinguzi N, Kidoguchi L, Mugo NR, et al. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy. BMC Public Health. 2020 Oct 28;20:1621.
  • Muessig KE, Cohen MS. Advances in HIV prevention for serodiscordant couples. Curr HIV/AIDS Rep. 2014 Dec;11:434–446.
  • Skovdal M, Campbell C, Nyamukapa C, et al. When masculinity interferes with women’s treatment of HIV infection: a qualitative study about adherence to antiretroviral therapy in Zimbabwe. J Int AIDS Soc. 2011 Jun 9;14:29.
  • Conroy A, Leddy A, Johnson M, et al. ‘I told her this is your life’: relationship dynamics, partner support and adherence to antiretroviral therapy among South African couples. Cult Health Sex. 2017 Nov 2;19:1239–1253.
  • Gilbert HN, Wyatt MA, Pisarski EE, et al. PrEP discontinuation and prevention-effective adherence: experiences of PrEP users in Ugandan HIV serodiscordant couples. JAIDS J Acquir Immune Defic Syndr. 2019 Nov 1;82:265–274.
  • Bhagwanjee A, Govender K, Reardon C, et al. Gendered constructions of the impact of HIV and AIDS in the context of the HIV-positive seroconcordant heterosexual relationship. J Int AIDS Soc [Internet]. 2013 May 15 [cited 2021 Mar 8];16:18021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656196/
  • Corneli A, Perry B, McKenna K, et al. Participants’ explanations for nonadherence in the FEM-PrEP clinical trial. JAIDS J Acquir Immune Defic Syndr. 2016 Apr 1;71:452–461.
  • Pintye J, Beima-Sofie KM, Makabong’O PA, et al. HIV-uninfected kenyan adolescent and young women share perspectives on using pre-exposure prophylaxis during pregnancy. AIDS Patient Care STDs. 2018 Dec;32:538–544.
  • Camlin CS, Koss CA, Getahun M, et al. Understanding demand for PrEP and early experiences of PrEP use among young adults in rural Kenya and Uganda: a qualitative study. AIDS Behav. 2020 Jan 18;24:2149–2162.
  • Roberts ST, Haberer J, Celum C, et al. Intimate partner violence and adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV serodiscordant relationships: a prospective cohort study. J Acquir Immune Defic Syndr 1999. 2016 Nov 1;73:313–322.
  • Chan BT, Tsai AC. HIV stigma trends in the general population during antiretroviral treatment expansion: analysis of 31 countries in sub-Saharan Africa, 2003–2013. JAIDS J Acquir Immune Defic Syndr. 2016 Aug 15;72:558–564.
  • Chan BT, Maughan-Brown BG, Bogart LM, et al. Trajectories of HIV-related internalized stigma and disclosure concerns among ART initiators and non-initiators in South Africa. Stigma Health. 2019 Nov;4:433–441.
  • Ashaba S, Cooper-Vince C, Vořechovská D, et al. Community beliefs, HIV stigma, and depression among adolescents living with HIV in rural Uganda. Afr J AIDS Res AJAR. 2019 Sep;18:169–180.
  • Velloza J, Khoza N, Scorgie F, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020 Mar;23:e25463.
  • Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV/AIDS Rep. 2018 Apr;15:190–197.
  • Eakle R, Weatherburn P, Bourne A. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale‐up: a synthesis of evidence from sub‐Saharan Africa. J Int AIDS Soc. [Internet]. 2019 Jul 22 [cited 2020 May 19];22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643067/
  • Gucciardi E, Jean-Pierre N, Karam G, et al. Designing and delivering facilitated storytelling interventions for chronic disease self-management: a scoping review. BMC Health Serv Res. 2016 Jul 11;16:249.
  • McCabe JA. Integrating mnemonics into psychology instruction [Internet]. Baltimore, MD: Goucher College; 2011. Available from: http://teachpsych.org/resources/Documents/otrp/resources/mccabe11.pdf
  • Johnson DR, Huffman BL, Jasper DM. Changing race boundary perception by reading narrative fiction. Basic Appl Soc Psychol. 2014 Jan 1;36:83–90.
  • Green MC, Brock TC. The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol. 2000 Nov;79:701–721.
  • O’Malley G, Barnabee G, Mugwanya K. Scaling-up PrEP delivery in Sub-Saharan Africa: what can we learn from the scale-up of ART? Curr HIV/AIDS Rep. 2019;16:141–150.
  • Ncama BP, McInerney PA, Bhengu BR, et al. Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud. 2008 Dec;45:1757–1763.
  • Yehia BR, Stewart L, Momplaisir F, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis. 2015 Dec;15:1–10.
  • Roy M, Czaicki N, Holmes C, et al. Understanding sustained retention in HIV/AIDS care and treatment: a synthetic review. Curr HIV/AIDS Rep. 2016 Jun;13:177–185.